Sign Up Today and Learn More About Aspect Biosystems Stock
Invest in or calculate the value of your shares in Aspect Biosystems or other pre-IPO companies through EquityZen's platform.
Aspect Biosystems Stock (ASPB)
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
About Aspect Biosystems Stock
Founded
2013
Industries
Software, Artificial Intelligence, Data and Analytics
Aspect Biosystems Press Mentions
Stay in the know about the latest news on Aspect Biosystems
Healthcare 3D Printing Market Size, Growth Drivers and Global Forecast 2035 | At a Thriving CAGR of 10.19%
einpresswire • Apr 14, 2025
3D Bioprinting Market Worth US$2.4 billion | MarketsandMarkets™.
globenewswire • Apr 08, 2025
Healthcare 3d Printing Market Expected to Achieve a Strong 10.19% CAGR, to Reach USD 8.5 Billion by 2035
einpresswire • Mar 17, 2025
Bioprinting methods and systems
patents • Feb 07, 2025
Theranostic device for cancer immunotherapy
patents • Feb 07, 2025
Aspect Biosystems Management
Leadership team at Aspect Biosystems
Co-founder & CEO
Tamer Mohamed
Co-founder & Chief Technology Officer
Simon Beyer
Join now and verify your accreditation status to gain access to:
- Aspect Biosystems Current Valuation
- Aspect Biosystems Stock Price
- Aspect Biosystems Management
- Available deals in Aspect Biosystems and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Aspect Biosystems Cap Table and Funding History by Share Class and Liquidity Preferences
- Aspect Biosystems Revenue and Financials
- Aspect Biosystems Highlights
- Aspect Biosystems Business Model
- Aspect Biosystems Risk Factors
- Aspect Biosystems Research Report from SACRA Research
Trading Aspect Biosystems Stock
How to invest in Aspect Biosystems stock?
Accredited investors can buy pre-IPO stock in companies like Aspect Biosystems through EquityZen funds. These investments are made available by existing Aspect Biosystems shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aspect Biosystems stock?
Shareholders can sell their Aspect Biosystems stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
